<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The involvement of potassium channels in the vasorelaxant effect was assessed following the experimental procedure previously detailed, with some variations [
 <xref ref-type="bibr" rid="CR54" class="xref">54</xref>]. Endothelium-intact rings were incubated with the Ca
 <sup class="sup">2+</sup>-activated potassium channels, TEA (10
 <sup class="sup">−2</sup>M; 
 <italic class="italic">n</italic> = 6), the selective voltage-activated potassium channel (K
 <sub class="sub">
  <italic class="italic">v</italic>
 </sub>) blocker, 4-AP (10
 <sup class="sup">−4</sup>M; 
 <italic class="italic">n</italic> = 6), the selective inwardly-rectifying potassium channel blocker, BaCl
 <sub class="sub">2</sub> (10
 <sup class="sup">−4</sup>M; 
 <italic class="italic">n</italic> = 6), and the selective ATP-sensitive potassium channel blocker, glybenclamide (10
 <sup class="sup">−5</sup>M; 
 <italic class="italic">n</italic> = 6) for 20 min prior to contraction with Phen (1 μM), then, the cumulative concentration–response curves of AcEO were constructed and compared with those obtained with untreated rings.
</p>
